Actavis, Purdue reach deal on abuse-resistant OxyContin generic

04/29/2013 | Drug Store News

Actavis may begin selling limited quantities of a generic, abuse-resistant form of Purdue Pharma's opioid painkiller OxyContin on Jan. 1, 2014, under a deal reached by the two drugmakers. If the FDA does not approve Actavis' generic version, the deal allows the company to sell an authorized generic.

View Full Article in:

Drug Store News